Cargando…

SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials

High quality protocols facilitate proper conduct, reporting, and external review of clinical trials. However, the completeness of trial protocols is often inadequate. To help improve the content and quality of protocols, an international group of stakeholders developed the SPIRIT 2013 Statement (Sta...

Descripción completa

Detalles Bibliográficos
Autores principales: Chan, An-Wen, Tetzlaff, Jennifer M, Gøtzsche, Peter C, Altman, Douglas G, Mann, Howard, Berlin, Jesse A, Dickersin, Kay, Hróbjartsson, Asbjørn, Schulz, Kenneth F, Parulekar, Wendy R, Krleža-Jerić, Karmela, Laupacis, Andreas, Moher, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group Ltd. 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3541470/
https://www.ncbi.nlm.nih.gov/pubmed/23303884
http://dx.doi.org/10.1136/bmj.e7586
_version_ 1782255365936644096
author Chan, An-Wen
Tetzlaff, Jennifer M
Gøtzsche, Peter C
Altman, Douglas G
Mann, Howard
Berlin, Jesse A
Dickersin, Kay
Hróbjartsson, Asbjørn
Schulz, Kenneth F
Parulekar, Wendy R
Krleža-Jerić, Karmela
Laupacis, Andreas
Moher, David
author_facet Chan, An-Wen
Tetzlaff, Jennifer M
Gøtzsche, Peter C
Altman, Douglas G
Mann, Howard
Berlin, Jesse A
Dickersin, Kay
Hróbjartsson, Asbjørn
Schulz, Kenneth F
Parulekar, Wendy R
Krleža-Jerić, Karmela
Laupacis, Andreas
Moher, David
author_sort Chan, An-Wen
collection PubMed
description High quality protocols facilitate proper conduct, reporting, and external review of clinical trials. However, the completeness of trial protocols is often inadequate. To help improve the content and quality of protocols, an international group of stakeholders developed the SPIRIT 2013 Statement (Standard Protocol Items: Recommendations for Interventional Trials). The SPIRIT Statement provides guidance in the form of a checklist of recommended items to include in a clinical trial protocol. This SPIRIT 2013 Explanation and Elaboration paper provides important information to promote full understanding of the checklist recommendations. For each checklist item, we provide a rationale and detailed description; a model example from an actual protocol; and relevant references supporting its importance. We strongly recommend that this explanatory paper be used in conjunction with the SPIRIT Statement. A website of resources is also available (www.spirit-statement.org). The SPIRIT 2013 Explanation and Elaboration paper, together with the Statement, should help with the drafting of trial protocols. Complete documentation of key trial elements can facilitate transparency and protocol review for the benefit of all stakeholders.
format Online
Article
Text
id pubmed-3541470
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BMJ Publishing Group Ltd.
record_format MEDLINE/PubMed
spelling pubmed-35414702013-01-10 SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials Chan, An-Wen Tetzlaff, Jennifer M Gøtzsche, Peter C Altman, Douglas G Mann, Howard Berlin, Jesse A Dickersin, Kay Hróbjartsson, Asbjørn Schulz, Kenneth F Parulekar, Wendy R Krleža-Jerić, Karmela Laupacis, Andreas Moher, David BMJ Research Methods & Reporting High quality protocols facilitate proper conduct, reporting, and external review of clinical trials. However, the completeness of trial protocols is often inadequate. To help improve the content and quality of protocols, an international group of stakeholders developed the SPIRIT 2013 Statement (Standard Protocol Items: Recommendations for Interventional Trials). The SPIRIT Statement provides guidance in the form of a checklist of recommended items to include in a clinical trial protocol. This SPIRIT 2013 Explanation and Elaboration paper provides important information to promote full understanding of the checklist recommendations. For each checklist item, we provide a rationale and detailed description; a model example from an actual protocol; and relevant references supporting its importance. We strongly recommend that this explanatory paper be used in conjunction with the SPIRIT Statement. A website of resources is also available (www.spirit-statement.org). The SPIRIT 2013 Explanation and Elaboration paper, together with the Statement, should help with the drafting of trial protocols. Complete documentation of key trial elements can facilitate transparency and protocol review for the benefit of all stakeholders. BMJ Publishing Group Ltd. 2013-01-09 /pmc/articles/PMC3541470/ /pubmed/23303884 http://dx.doi.org/10.1136/bmj.e7586 Text en © Chan et al 2013 This is an open-access article distributed under the terms of the Creative Commons Attribution Non-commercial License, which permits use, distribution, and reproduction in any medium, provided the original work is properly cited, the use is non commercial and is otherwise in compliance with the license. See: http://creativecommons.org/licenses/by-nc/2.0/ and http://creativecommons.org/licenses/by-nc/2.0/legalcode.
spellingShingle Research Methods & Reporting
Chan, An-Wen
Tetzlaff, Jennifer M
Gøtzsche, Peter C
Altman, Douglas G
Mann, Howard
Berlin, Jesse A
Dickersin, Kay
Hróbjartsson, Asbjørn
Schulz, Kenneth F
Parulekar, Wendy R
Krleža-Jerić, Karmela
Laupacis, Andreas
Moher, David
SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials
title SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials
title_full SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials
title_fullStr SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials
title_full_unstemmed SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials
title_short SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials
title_sort spirit 2013 explanation and elaboration: guidance for protocols of clinical trials
topic Research Methods & Reporting
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3541470/
https://www.ncbi.nlm.nih.gov/pubmed/23303884
http://dx.doi.org/10.1136/bmj.e7586
work_keys_str_mv AT chananwen spirit2013explanationandelaborationguidanceforprotocolsofclinicaltrials
AT tetzlaffjenniferm spirit2013explanationandelaborationguidanceforprotocolsofclinicaltrials
AT gøtzschepeterc spirit2013explanationandelaborationguidanceforprotocolsofclinicaltrials
AT altmandouglasg spirit2013explanationandelaborationguidanceforprotocolsofclinicaltrials
AT mannhoward spirit2013explanationandelaborationguidanceforprotocolsofclinicaltrials
AT berlinjessea spirit2013explanationandelaborationguidanceforprotocolsofclinicaltrials
AT dickersinkay spirit2013explanationandelaborationguidanceforprotocolsofclinicaltrials
AT hrobjartssonasbjørn spirit2013explanationandelaborationguidanceforprotocolsofclinicaltrials
AT schulzkennethf spirit2013explanationandelaborationguidanceforprotocolsofclinicaltrials
AT parulekarwendyr spirit2013explanationandelaborationguidanceforprotocolsofclinicaltrials
AT krlezajerickarmela spirit2013explanationandelaborationguidanceforprotocolsofclinicaltrials
AT laupacisandreas spirit2013explanationandelaborationguidanceforprotocolsofclinicaltrials
AT moherdavid spirit2013explanationandelaborationguidanceforprotocolsofclinicaltrials